TickerFacts.

A business in context

MCK research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-25 · 0000927653-26-000247 · Items 7.01,9.01

  2. 4 · Ownership change

    Report date 2026-08-07 · 0000927653-26-000240

  3. 4 · Ownership change

    Report date 2026-08-10 · 0000927653-26-000239

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000927653-26-000234

  5. 8-K · Current report

    Report date 2026-08-05 · 0000927653-26-000232 · Items 2.02,9.01

  6. 8-K · Current report

    Report date 2026-07-22 · 0000927653-26-000215 · Items 5.07

  7. 4 · Ownership change

    Report date 2026-07-22 · 0000927653-26-000209

  8. 4 · Ownership change

    Report date 2026-07-22 · 0000927653-26-000208

  9. 4 · Ownership change

    Report date 2026-07-22 · 0000927653-26-000207

  10. 4 · Ownership change

    Report date 2026-07-22 · 0000927653-26-000206

  11. 4 · Ownership change

    Report date 2026-07-22 · 0000927653-26-000205

  12. 4 · Ownership change

    Report date 2026-07-22 · 0000927653-26-000204

  13. 8-K · Current report

    Report date 2026-06-29 · 0000927653-26-000185 · Items 5.02,7.01,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-03-31 · 0000927653-26-000169

  15. 8-K · Current report

    Report date 2026-06-09 · 0000927653-26-000167 · Items 1.01,2.03,9.01

  16. 10-K · Annual report

    Report date 2026-03-31 · 0000927653-26-000069

  17. 8-K · Current report

    Report date 2026-05-07 · 0000927653-26-000066 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2026-04-28 · 0000927653-26-000053 · Items 1.01,1.02,2.03,9.01

  19. 8-K · Current report

    Report date 2026-04-01 · 0000927653-26-000045 · Items 1.01,2.03,9.01

  20. 8-K · Current report

    Report date 2026-03-06 · 0000927653-26-000038 · Items 7.01,9.01

  21. 8-K · Current report

    Report date 2026-03-03 · 0000927653-26-000035 · Items 5.02,9.01

  22. 10-Q · Quarterly report

    Report date 2025-12-31 · 0000927653-26-000017

  23. 8-K · Current report

    Report date 2026-02-04 · 0000927653-26-000015 · Items 2.02,9.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000927653-25-000140

  25. 8-K · Current report

    Report date 2025-11-05 · 0000927653-25-000138 · Items 2.02,9.01

  26. 8-K · Current report

    Report date 2025-09-23 · 0000927653-25-000125 · Items 7.01,9.01

  27. 8-K · Current report

    Report date 2025-09-18 · 0000927653-25-000121 · Items 2.02,8.01,9.01

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000927653-25-000107

  29. 8-K · Current report

    Report date 2025-08-06 · 0000927653-25-000105 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-07-30 · 0000927653-25-000096 · Items 5.07

  31. DEF 14A · Proxy statement

    Report date 2025-03-31 · 0000927653-25-000061

  32. 8-K · Current report

    Report date 2025-06-09 · 0000927653-25-000045 · Items 7.01

  33. 8-K · Current report

    Report date 2025-05-20 · 0001628280-25-028495 · Items 2.03,8.01,9.01

  34. 10-K · Annual report

    Report date 2025-03-31 · 0000927653-25-000036

  35. 8-K · Current report

    Report date 2025-05-08 · 0000927653-25-000034 · Items 2.02,9.01

  36. 10-Q · Quarterly report

    Report date 2024-12-31 · 0000927653-25-000014

  37. 8-K/A · Current report

    Report date 2025-02-05 · 0000927653-25-000012 · Items 2.02,9.01

  38. 8-K · Current report

    Report date 2025-02-05 · 0000927653-25-000010 · Items 2.02,9.01

  39. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000927653-24-000125

  40. 8-K · Current report

    Report date 2024-11-06 · 0000927653-24-000121 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 8 transaction rows8SGrant / award: 16 transaction rows16AExercise / conversion: 40 transaction rows40MTax / exercise payment: 28 transaction rows28FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

92 matching transaction rows. Showing 51–92.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-05-20
2026-05-22
Fraga FranciscoF · Tax / exercise payment
Disposed
Common Stock183.0754.68
2026-05-20
2026-05-22
Fraga FranciscoM · Exercise / conversion
Disposed
Restricted Stock Units (RSUs)
Derivative security
463.00.0
2026-05-20
2026-05-22
Lau MicheleM · Exercise / conversion
Acquired
Common Stock677.00.0
2026-05-20
2026-05-22
Lau MicheleF · Tax / exercise payment
Disposed
Common Stock267.0754.68
2026-05-20
2026-05-22
Lau MicheleM · Exercise / conversion
Disposed
Restricted Stock Units (RSUs)
Derivative security
677.00.0
2026-05-20
2026-05-22
Rutledge Napoleon B JRM · Exercise / conversion
Acquired
Common Stock74.00.0
2026-05-20
2026-05-22
Rutledge Napoleon B JRF · Tax / exercise payment
Disposed
Common Stock22.0754.68
2026-05-20
2026-05-22
Rutledge Napoleon B JRM · Exercise / conversion
Disposed
Restricted Stock Units (RSUs)
Derivative security
74.00.0
2026-05-20
2026-05-22
Rodgers Thomas LM · Exercise / conversion
Acquired
Common Stock324.00.0
2026-05-20
2026-05-22
Rodgers Thomas LF · Tax / exercise payment
Disposed
Common Stock128.0754.68
2026-05-20
2026-05-22
Rodgers Thomas LM · Exercise / conversion
Disposed
Restricted Stock Units (RSUs)
Derivative security
324.00.0
2026-05-20
2026-05-22
Smith LeAnn BM · Exercise / conversion
Acquired
Common Stock463.00.0
2026-05-20
2026-05-22
Smith LeAnn BF · Tax / exercise payment
Disposed
Common Stock183.0754.68
2026-05-20
2026-05-22
Smith LeAnn BM · Exercise / conversion
Disposed
Restricted Stock Units (RSUs)
Derivative security
463.00.0
2026-05-20
2026-05-22
Vitalone Britt J.M · Exercise / conversion
Acquired
Common Stock1038.00.0
2026-05-20
2026-05-22
Vitalone Britt J.F · Tax / exercise payment
Disposed
Common Stock409.0754.68
2026-05-20
2026-05-22
Vitalone Britt J.M · Exercise / conversion
Disposed
Restricted Stock Units (RSUs)
Derivative security
1038.00.0
2026-05-20
2026-05-22
TYLER BRIAN S.F · Tax / exercise payment
Disposed
Common Stock1282.0754.68
2026-05-20
2026-05-22
TYLER BRIAN S.M · Exercise / conversion
Acquired
Common Stock3189.00.0
2026-05-20
2026-05-22
TYLER BRIAN S.M · Exercise / conversion
Disposed
Restricted Stock Units (RSUs)
Derivative security
3189.00.0
2026-05-19
2026-05-21
TYLER BRIAN S.F · Tax / exercise payment
Disposed
Common Stock10937.0761.89
2026-05-19
2026-05-21
TYLER BRIAN S.A · Grant / award
Acquired
Common Stock27863.00.0
2026-05-19
2026-05-21
TYLER BRIAN S.A · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
9739.00.0
2026-05-19
2026-05-21
Vitalone Britt J.A · Grant / award
Acquired
Common Stock8979.00.0
2026-05-19
2026-05-21
Vitalone Britt J.F · Tax / exercise payment
Disposed
Common Stock3338.0761.89
2026-05-19
2026-05-21
Smith LeAnn BA · Grant / award
Acquired
Common Stock4129.00.0
2026-05-19
2026-05-21
Smith LeAnn BF · Tax / exercise payment
Disposed
Common Stock1523.0761.89
2026-05-19
2026-05-21
Smith LeAnn BA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
1471.00.0
2026-05-19
2026-05-21
Rodgers Thomas LA · Grant / award
Acquired
Common Stock3614.00.0
2026-05-19
2026-05-21
Rodgers Thomas LF · Tax / exercise payment
Disposed
Common Stock1226.0761.89
2026-05-19
2026-05-21
Rodgers Thomas LA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
919.00.0
2026-05-19
2026-05-21
Lau MicheleA · Grant / award
Acquired
Common Stock4454.00.0
2026-05-19
2026-05-21
Lau MicheleF · Tax / exercise payment
Disposed
Common Stock1753.0761.89
2026-05-19
2026-05-21
Lau MicheleA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
1969.00.0
2026-05-19
2026-05-21
Rutledge Napoleon B JRA · Grant / award
Acquired
Common Stock788.00.0
2026-05-19
2026-05-21
Rutledge Napoleon B JRF · Tax / exercise payment
Disposed
Common Stock234.0761.89
2026-05-19
2026-05-21
Rutledge Napoleon B JRA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
211.00.0
2026-05-19
2026-05-21
Fraga FranciscoA · Grant / award
Acquired
Common Stock788.00.0
2026-05-19
2026-05-21
Fraga FranciscoF · Tax / exercise payment
Disposed
Common Stock843.0761.89
2026-05-19
2026-05-21
Fraga FranciscoA · Grant / award
Acquired
Common Stock2339.00.0
2026-05-19
2026-05-21
Fraga FranciscoF · Tax / exercise payment
Disposed
Common Stock192.0761.89
2026-05-19
2026-05-21
Fraga FranciscoA · Grant / award
Acquired
Restricted Stock Units (RSUs)
Derivative security
1576.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000927653MCKESSON CORP
McKesson Europe AGHealth MartRemedy'sRxGuardianI.D.A.US Oncology NetworkNorsk Medisinaldepot

Showing 7 of 7 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300WZWOM80UCFSF54
GLEIF legal name
MCKESSON CORPORATION
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-01-30T08:04:06Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • McKesson Corporation · alias · wikidata
  • McKesson Health Solutions · alias · wikidata
  • McKesson · alias · wikidata
  • McKesson Europe AG · subsidiary · wikidata
  • Celesio AG · subsidiary · wikidata
  • Health Mart · subsidiary · wikidata
  • Health Mart Pharmacy · subsidiary · wikidata
  • Remedy'sRx · subsidiary · wikidata
  • Guardian · subsidiary · wikidata
  • Guardian Pharmacy · subsidiary · wikidata
  • Guardian Drugs · subsidiary · wikidata
  • I.D.A. · subsidiary · wikidata
  • IDA Pharmacy · subsidiary · wikidata
  • IDA · subsidiary · wikidata
  • US Oncology Network · subsidiary · wikidata
  • Norsk Medisinaldepot · subsidiary · wikidata
  • MCKESSON HBOC INC · former SEC name · 1999-09-10 to 2001-08-13
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2025-03-31$359.05B$379.65B
2024-03-31$308.95B$335.89B
2023-03-31$276.71B$311.35B
2022-03-31$263.97B$319.14B
2021-03-31$238.23B$305.92B
2020-03-31$231.05B$300.21B
2019-03-31$214.32B$283.84B
2018-03-31$208.36B$282.30B

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗